Industry News

Medical Device Industry News

Neurostimulation Devices Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 17.49 Billion by 2030: Verified Market Research®

April 28th, 2023|Medical Device News Magazine|

The "Global Neurostimulation Devices Market Size By Devices Type (Implantable Devices, External Devices), By Application (Parkinson's Disease, Epilepsy), By End-User (Rehabilitation Centers, Hospitals), By Geographic Scope & Forecast, 2023-2030" report has been published by Verified

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

April 28th, 2023|Medical Device News Magazine|

Charlie Goodwin, President and Chief Executive Officer of Apyx Medical. “This 510(k) clearance further demonstrates the safety and effectiveness of our Renuvion technology, and our continued commitment to working with the FDA to secure specific

Nuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

April 28th, 2023|Medical Device News Magazine|

Nuvo Group is committed to reinventing pregnancy care for the 21st century through new technology, tools, and practices for providers and expectant mothers, including the INVU by Nuvo™ platform, an FDA-cleared, prescription initiated remote pregnancy

Protect Yourself from Medicare Scams

April 28th, 2023|Medical Device News Magazine|

(Family Features) Since 1965, Medicare has provided health care coverage to millions of Americans. More than 65 million people in the United States were enrolled in Medicare as of February 2023, with more people becoming

ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders

April 28th, 2023|Medical Device News Magazine|

Jeff Elton, Ph.D., CEO of ConcertAI: "ConcertAI's TeraRecon Eureka Clinical AI offers a portfolio of solutions from the AI leaders in the neurology field, including Combinostics, Imaging Biometrics, and Cercare, creating a first-in-class capability and